Vetter Implements New Serialization Services - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Vetter Implements New Serialization Services


PTSM: Pharmaceutical Technology Sourcing and Management
Volume 10, Issue 4
Vetter has reported progress in its solution for product packaging, designed to support the prevention of product counterfeiting. This new development is in response to expanded requirements by official regulatory agencies that require manufacturers to have clear identification of drugs on packaging. Vetter is implementing its IT-solution and will offer its customers a range of serialization services as a basis for track-and-trace programs by the end of 2014.

One improvement of these new sterilization services include printing global trade item numbers (GTIN) on packages. These services will support pharmaceutical and biotech companies in implementing their own track-and-trace programs for a secured and controlled supply chain.

Source: Vetter

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
30%
Breakthrough designations
9%
Protecting the supply chain
39%
Expedited reviews of drug submissions
9%
More stakeholder involvement
13%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here